Apyx Medical Corporation (NASDAQ:APYX) Q1 2021 Earnings Conference Call May 12, 2021 8:00 AM ET Company Participants Charlie Goodwin - President & CEO Tara Semb - CFO Conference Call Participants Dave Turkaly - JMP Securities Matt Hewitt - Craig-Hallum Korinne Wolfmeyer - Piper Sandler Russell Cleveland - RENN Capital Operator Good morning, ladies and gentlemen, and welcome to the First Quarter of Fiscal Year 2021 Earnings Conference Call for Apyx Medical Corporation. At this time, all participants have bee ...

Apyx Medical Corporation (NASDAQ:APYX) Q4 2020 Results Conference Call March 31, 2021 8:00 AM ET Company Participants Charlie Goodwin - President and Chief Executive Officer Tara Semb - Chief Financial Officer Conference Call Participants Matthew O'Brien - Piper Sandler Matt Hewitt - Craig-Hallum Kyle Bauser - Colliers Securities Russell Cleveland - RENN Capital Operator Good morning, ladies and gentlemen, and welcome to the Fourth Quarter and Fiscal Year 2020 Earnings Conference Call for Apyx Medical Cor ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Title of each class Trading symbol(s) Name of each exchange on which registered Common Stock APYX Nasdaq Stock Market, LLC FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission File Number: 0-1 ...

Apyx Medical Corporation (NASDAQ:APYX) Q3 2020 Earnings Conference Call November 9, 2020 8:00 AM ET Company Participants Charlie Goodwin - President and Chief Executive Officer Tara Semb - Chief Financial Officer Conference Call Participants David Turkaly - JMP Securities Matthew O’Brien - Piper Sandler Matt Hewitt - Craig-Hallum Capital Group Kyle Bauser - Colliers Securities Russell Cleveland - Renn Capital Operator Good morning, ladies and gentlemen and welcome to the Third Quarter of Fiscal Year 2020 Ea ...

Apyx Medical Corporation (NASDAQ:APYX) Q2 2020 Results Earnings Conference Call August 10, 2020 8:00 AM ET Company Participants Charlie Goodwin - President and Chief Executive Officer Tara Semb - Chief Financial Officer Conference Call Participants Matt Hewitt - Craig-Hallum Matthew O'Brien - Piper Jaffray Dave Turkaly - JMP Securities Kyle Bauser - Colliers Securities Russell Cleveland - Renn Capital Operator Good morning, ladies and gentlemen, and welcome to the Second Quarter Fiscal-Year 2020 Earnings Co ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Title of each class Trading symbol(s) Name of each exchange on which registered Common Stock APYX Nasdaq Stock Market, LLC Large accelerated filer ☐ Accelerated filer ☒ Non-accelerated filer ☐ Smaller reporting company ☒ FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES E ...

Apyx Medical Corp (NASDAQ:APYX) Q1 2020 Results Earnings Conference Call May 11, 2020 8:00 AM ET Company Participants Charlie Goodwin - President and Chief Executive Officer Tara Semb - Chief Financial Officer Conference Call Participants Kyle Bauser - Dougherty & Company Matt Hewitt - Craig-Hallum Capital Jerome Day - Piper Sandler Operator Good morning, ladies and gentlemen, and welcome to the First Quarter Fiscal-Year 2020 Earnings Call for Apyx Medical Corporation [Operator instructions]. Please note t ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Title of each class Trading symbol(s) Name of each exchange on which registered Common Stock APYX Nasdaq Stock Market, LLC FORM 10-Q ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission File Number: 0-12183 ...